Fact checked byRichard Smith

Read more

March 05, 2024
2 min read
Save

COVID-19 vaccine availability not tied to change in incidence of abnormal uterine bleeding

Fact checked byRichard Smith
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Abnormal uterine bleeding incidence had no significant change in the pre-pandemic period vs. the post-vaccine period.
  • Most commonly reported symptoms were changes in timing, duration and volume of bleeding.

COVID-19 vaccination availability was not associated with changes in abnormal uterine bleeding incidence for women of reproductive age, researchers reported in the American Journal of Obstetrics and Gynecology.

“There is evidence that COVID-19 vaccination could have short-term impacts on menstrual symptoms, including changes in menstruation timing, flow, duration and pain, for some individuals. Changes in uterine bleeding can cause anxiety about reproductive health and negatively impact quality of life,” Neon Brooks, PhD, research associate in the Vaccine Safety Datalink at Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues wrote. “Little is known about whether, among premenopausal individuals, changes in uterine bleeding following COVID-19 vaccination cause sufficient concern to increase health care visits.”

vaccination_STOCK
Abnormal uterine bleeding incidence had no significant change in the pre-pandemic period vs. the post-vaccine period. Image: Adobe Stock.

Brooks and colleagues evaluated whether availability of the COVID-19 vaccine was associated with changes in monthly population-based rates of incident abnormal uterine bleeding diagnoses compared with the pre-pandemic period among premenopausal women aged 16 to 44 years who were health system members. Researchers compared clinical and demographic characteristics of women with incident abnormal uterine bleeding from December 2020 to October 2021 based on whether they were vaccinated in the 60 days before diagnosis, vaccinated more than 60 days before diagnosis or never vaccinated.

Abnormal uterine bleeding incidence per 100,000 person-days ranged from 8.97 to 19.19 in the monthly female health system member populations that ranged from 79,000 to 85,000 women.

Researchers observed no significant change in the level or trend for abnormal uterine bleeding incidence from January 2019 to January 2020 in the pre-pandemic period and from December 2020 to December 2021 in the post-COVID-19 vaccine period. When comparing 2,717 abnormal uterine bleeding cases based on vaccination status, results suggested that abnormal bleeding in recently vaccinated women was similar or less severe compared with abnormal bleeding in women who were never vaccinated or those who were vaccinated more than 60 days before their diagnosis.

Researchers noted significant differences in age and race of women with abnormal uterine bleeding diagnoses based on vaccination status, as women who were never vaccinated were the youngest and women who were vaccinated more than 60 days before their diagnosis were the oldest. In addition, the highest proportion of Black women was observed among those who were never vaccinated, and the higher proportion of Asian women was observed among those who were vaccinated.

The most commonly reported symptoms were changes in timing, duration and volume of bleeding, according to a chart review of 114 confirmed post-vaccination abnormal uterine bleeding cases diagnosed from December 2020 to October 2021. About one-third of cases had no diagnostic workup, with 57% having no etiology for bleeding documented in electronic health records, the researchers wrote. Also, in 12% of cases, women mentioned or asked about a possible link between their uterine bleeding and recent COVID-19 vaccination.

“Although a small proportion of cases mentioned or asked about vaccination as a possible cause of their symptoms, our results suggest that COVID-19 vaccination did not result in an increase in health care seeking and diagnoses for abnormal uterine bleeding,” the researchers wrote.